Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond

The therapeutic landscape of several genitourinary malignancies has been revolutionized by the development of immune checkpoint inhibitors (ICIs); however, the utility of immunotherapies in prostate cancer has been limited, partly due to the immunologically “cold” tumor terrain of prostate cancer. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanka, Sree M., Zorko, Nicholas A., Antonarakis, Emmanuel S., Barata, Pedro C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137248/
https://www.ncbi.nlm.nih.gov/pubmed/37185436
http://dx.doi.org/10.3390/curroncol30040323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137248/
https://www.ncbi.nlm.nih.gov/pubmed/37185436
http://dx.doi.org/10.3390/curroncol30040323

Ejemplares similares